Topical Timolol Gel for the Treatment of Infantile Hemangiomas
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
We plan to conduct a study, to see how safe and effective timolol maleate 0.5% gel-forming
solution is for infantile hemangiomas (IH) and the response of hemangiomas to timolol maleate
0.5% . Our hypothesis is that timolol will inhibit and possibly reverse growth of appropriate
infantile hemangiomas.